Ionis Pharmaceuticals, Inc. (IONS) vs TG Therapeutics, Inc. (TGTX)

A side-by-side comparison of Ionis Pharmaceuticals, Inc. and TG Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IONS vs TGTX

growth of $100 · dividends reinvested · last 10y
IONS +22.0% (+2.0%/yr)TGTX +540.3% (+20.4%/yr)TGTX compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020182020202220242026$122$640
IONS TGTX

IONS vs TGTX: by the numbers

  • •TGTX is the larger company ($7.99B vs $7.31B market cap).
  • •TGTX is profitable (55.22% net margin) while IONS runs a net loss (-64.64%).
  • •TGTX grew revenue faster over the past five years (219.22% vs 4.91% CAGR).

Metrics side by side

Valuation

MetricIONSTGTX
P/E ratioN/A19.05
Forward P/EN/A53.62
P/S ratio8.379.99
P/B ratio16.6313.23
EV / EBITDA2.2160.46
FCF yieldN/A0.22%

Profitability

MetricIONSTGTX
Gross margin98.16%82.36%
Operating margin-40.47%17.05%
Net margin-64.64%55.22%
ROE-128.44%73.08%
ROIC-20.37%9.94%

Growth (annualized)

MetricIONSTGTX
Revenue CAGR (5Y)4.91%219.22%
Total return CAGR (5Y)5.82%10.75%

Frequently asked

Which has grown faster, IONS or TGTX?
Over the past five years, TGTX grew revenue faster — IONS at a 4.91% CAGR versus TGTX at 219.22%.
Is IONS or TGTX more profitable?
TGTX runs the higher net margin — IONS at -64.64% versus TGTX at 55.22%.
How have IONS and TGTX total returns compared?
Over the past 10 years, IONS delivered 1.80% and TGTX delivered 20.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.